Health-related quality of life in patients with advanced, nonfunctional, well-differentiated gastrointestinal or lung neuroendocrine tumors with everolimus vs. placebo in the phase 3, randomized, RADIANT-4 trial
Marianne E Pavel, Simron Singh, Jonathan Strosberg, Lida Bubuteishvili Pacaud, Evgeny Degtyarev, MP Neary, Carlo Carnaghi, Jiri Tomasek, Edward Wolin, Markus Raderer, Harald Lahner, Juan Valle, Rodney Pommier, Eric Van Cutsem, M.E.T Tesselaar, Gianfranco Delle Fave, Roberto Buzzoni, Matthias Hunger, Jennifer Eriksson, David CellaJean-François Ricci, Nicola Fazio, Matthew H Kulke, James C Yao
Research output: Contribution to journal › Article › peer-review
57Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Health-related quality of life in patients with advanced, nonfunctional, well-differentiated gastrointestinal or lung neuroendocrine tumors with everolimus vs. placebo in the phase 3, randomized, RADIANT-4 trial'. Together they form a unique fingerprint.